Patent Number : Patent Number: (#1462836 International patent number : WO2016097643A1 Modèle de peau humaine et son utilisation pour évaluer ex vivo les effets dermatologiques, cosmétiques et/ou nutraceutiques de composés
Co-inventors T. Passeron
Patent Number : Patent Number: International patent number : EP 17306912.1 Novel biguanide compounds and amino-1,2,3-triazine compounds and their applications in oncology
Co-inventors S. Rocchi, R. Benhida C. Ronco O. Grytsai E. Jaune N.Tekaya
Patent Number : Patent Number: International patent number : EP15306213 Novel Substituted Hydrophobic Benzene Sulfonamide Thiazole Compounds
Co-inventors S. Rocchi, R. Ballotti M. Plaisant C. Ronco R. Benhida
Patent Number : Patent Number: 1970065.6 International patent number : EP 3 735 407 A1 Substituted halo-quinone derivatives for use in the treatment of lymphomas and leukemia.
Co-inventors T. Passeron, R. Benhida
Patent Number : Patent Number: 19700067.2 International patent number : EP 3 735 408 A1 Substituted halo-quinone derivatives, method of preparation and application thereof
Co-inventors R. Benhida
Patent Number : Patent Number: N° 19 305 179.4 International patent number : METHODS AND COMPOSITIONS FOR SELECTING A CANCER TREATMENT IN A SUBJECT SUFFERING FROM CANCER
Co-inventors N. Mazure, Lucilla Fabbri Maeva Dufies
Patent Number : Patent Number: N°19305762.7 International patent number : METHODS AND COMPOSITIONS FOR SELECTING A CANCER TREATMENT IN A SUBJECT SUFFERING FROM CANCER
Co-inventors N. Mazure, Lucilla Fabbri Maeva Dufies
Patent Number : Patent Number: WO 2012156928 A1 International patent number : WO 2012156928 A1 VDAC1-S as a cell marker (PR 92989)
Co-inventors N. Mazure
Patent Number : Patent Number: International patent number : EB19024 Diagnosis of myeloproliferative neoplasma
Patent Number : Patent Number: International patent number : MBIO17600 UPR targeting for the treatment of NASH and CHC